Andrew Cittadine - Net Worth and Insider Trading
Andrew Cittadine Net Worth
The estimated net worth of Andrew Cittadine is at least $585,565 dollars as of 2024-11-08. Andrew Cittadine is the COO of Monopar Therapeutics Inc and owns about 37,226 shares of Monopar Therapeutics Inc (MNPR) stock worth over $585,565. Details can be seen in Andrew Cittadine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Cittadine has not made any transactions after 2024-06-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andrew Cittadine
Andrew Cittadine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andrew Cittadine owns 1 companies in total, including Monopar Therapeutics Inc (MNPR) .
Click here to see the complete history of Andrew Cittadine’s form 4 insider trades.
Insider Ownership Summary of Andrew Cittadine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2024-06-20 | Chief Operating Officer |
Andrew Cittadine Latest Holdings Summary
Andrew Cittadine currently owns a total of 1 stock. Andrew Cittadine owns 37,226 shares of Monopar Therapeutics Inc (MNPR) as of June 20, 2024, with a value of $585,565.
Latest Holdings of Andrew Cittadine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2024-06-20 | 37,226 | 15.73 | 585,565 |
Holding Weightings of Andrew Cittadine
Andrew Cittadine Form 4 Trading Tracker
According to the SEC Form 4 filings, Andrew Cittadine has made a total of 5 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 6,502 shares on June 20, 2024, which cost Andrew Cittadine around $25,681.
Insider Trading History of Andrew Cittadine
- 1
Andrew Cittadine Trading Performance
GuruFocus tracks the stock performance after each of Andrew Cittadine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andrew Cittadine is 1%. GuruFocus also compares Andrew Cittadine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andrew Cittadine within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andrew Cittadine's insider trading performs compared to the benchmark.
Performance of Andrew Cittadine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.01 | | | | | |
| Relative Return to S&P 500(%) | -3.74 | | | | | |
Andrew Cittadine Ownership Network
Ownership Network List of Andrew Cittadine
Ownership Network Relation of Andrew Cittadine
Andrew Cittadine Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Andrew Cittadine is the Chief Operating Officer of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Financial Officer Kim R Tsuchimoto , director & Chief Executive Officer Chandler Robinson , and other: Acting Chief Medical Officer Patrice Rioux .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Andrew Cittadine made 4 insider transaction in Monopar Therapeutics Inc (MNPR) with a net purchase of 128,508. Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 1,550 shares made by Karthik Radhakrishnan ,
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 1,550 shares, with a net purchase of 1,550 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net purchase of 27,252 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Andrew Cittadine Mailing Address
Above is the net worth, insider trading, and ownership report for Andrew Cittadine. You might contact Andrew Cittadine via mailing address: C/o 1000 Skokie Blvd Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
